In 2023, TEDA saw an output value of 64.91 billion yuan from its healthcare industry.

Biopharmaceutical

·China’s Largest Insulin and Industrial Enzyme Preparations Production Base

·A Leader of CRO and CDMO Business Development in China

·A Major Pioneer in China’s Small Nucleic Acid Technology and Small Nucleic Acid Pharmaceutical Industry

TEDA is the core region for the biopharmaceutical industry in Tianjin and the Bohai Rim area. After forty years of growth, it has established a favorable trend of “leading enterprises driving cluster development”, forming a relatively complete biopharmaceutical industry chain and industrial ecosystem.

Covering eight growth priorities of the pharmaceutical industry:

Food & Beverage

The food and beverage industry is one of the traditional pillar industries in TEDA. Currently, it has established industrial clusters in beverages, edible oils, dairy products, instant foods, and functional foods, attracting many well-known domestic and international food giants. TEDA also brings together essential enterprises in food additives, food raw materials, food processing, food packaging materials, and food machinery, forming a complete industry chain.

Biomedicine:

Medical Devices:

CRO:

Food & Bevearges:

Big Health: